Translational Development Acquisition Corp.
corporate_fare Company Profile
Translational Development Acquisition Corp. (NASDAQ:TDAC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for TDAC at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Company Declares Disclosure Controls Ineffective Following SEC Scrutiny
- SPAC Seeks Shareholder Approval to Extend Business Combination Deadline to June 2027 Amidst Going Concern Warning
- SPAC Translational Development Acquisition Corp. Discloses Going Concern Risk with June 2026 Business Combination Deadline Looming
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
$6.36M
Op. Cash Flow
-$608.39K
Operating Income
-$944.54K
Cash & Equivalents
$29.79K
Debt / Equity
0.00×
Source: 10-K · filed 2026-05-11 · accession 0001104659-26-058544
show_chartPrice Chart
Loading chart...
feed TDAC - Filings & News (Page 2)
TDAC
May 11, 2026, 2:08 PM EDT
Price at Filing:
$10.63
Real-time Price:
$10.92
Change:
+$0.290 (+3%)
Market Cap:
$210.852M
TDAC
May 01, 2026, 5:28 PM EDT
Price at Filing:
$10.64
Real-time Price:
$10.92
Change:
+$0.280 (+3%)
Market Cap:
$210.852M
TDAC
Mar 30, 2026, 5:30 PM EDT
Price at Filing:
$10.58
Real-time Price:
$10.92
Change:
+$0.340 (+3%)
Market Cap:
$210.852M